Skip to main content
. 2012 Jan 24;6(3):323–332. doi: 10.1016/j.molonc.2012.01.004

Table 2.

SA1641‐mediated efficacy increase of different targeted toxins

SI50 (nM)a TEFb
Without SA1641 With SA1641
RTA‐EGF >1000 61 16.3
DT390EGF 8.8 0.73 12
EGF‐ETA' 128 103 1.2
Dianthin‐30‐EGF 0.45 <0.000 0001 >4,000,000
Saporin‐EGF 57 <0.000 0001 >4,000,000
a

50% cell survival.

b

TEF, toxicity enhancement factor (SI50 without SA1641/SI50 with SA1641), represents the x‐fold SA1641‐mediated efficacy increase of targeted toxins.